Gongwin Biopharm Holdings Co., Ltd. (TPEX:6617)

Gongwin Biopharm Holdings Revenue

In the year 2025, Gongwin Biopharm Holdings had annual revenue of 36.45M TWD with 13.75% growth. Gongwin Biopharm Holdings had revenue of 7.91M in the quarter ending December 31, 2025, a decrease of -11.40%.

• Revenue: 36.45M
• Revenue Growth: +13.75%
• P/S Ratio: 228.11
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 8.31B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	36.45M	4.41M	13.75%
Dec 31, 2024	32.04M	13.13M	69.39%
Dec 31, 2023	18.92M	17.77M	1,554.86%
Dec 31, 2022	1.14M	-	-
Dec 31, 2021	1.14M	310.00K	37.21%